Skip to content

Novel Empowering Solutions and Technologies for Older people to Retain Everyday life activities

Novel Empowering Solutions and Technologies for Older people to Retain Everyday life activities - NESTORE

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON49714
Enrollment
13
Registered
2020-02-20
Start date
2020-09-30
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General prevention for maintaining health maintaining independence prevention

Interventions

ICT-mediated coaching activities to maintain or improve state in four domains: physical, nutritional, cognitive and social

Sponsors

Preventie Collectief VOF
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Age: between 65 and 75 years. Community dwelling, living in their own home. Independent for all instrumental activities of Lawton & Brody index (phone use, shopping, preparing meals, housekeeping, laundry, transportation, use of medication, handle finances) Physically high functioning, with at least a score of 9+ points in the Short Physical Performance Battery. Preserved cognition, with at least a score of 24 points in the Mini Mental State Examination (MMSE). Able to use information and communication technology devices. With enough skills to install apps and shoot pictures in a smartphone. Availability of the minimum technical system requirements at home: WIFI connection and a tablet or smartphone with Android 7.0 or newer and Bluetooth connectivity. Voluntarily agreeing to participate providing informed consent.

Exclusion criteria

Exclusion criteria: Persons involved in another clinical trial. Persons reporting deficient vision. Persons reporting deficient hearing. Presence of 2 or more symptoms of the Geriatric Depression Scale. Presence of the following chronic conditions diagnosed by a doctor: cardiovascular, metabolic, neurologic, immunologic, respiratory, kidney diseases or diabetes in treatment with insulin. Note: Persons with hypertension under pharmacological control, hypercholesterolemia, hypertriglyceridemia, arthrosis, diabetes not treated with insulin, osteoporosis or constipation can participate in the study.

Design outcomes

Primary

MeasureTime frame
Feasibility assessment is done with log files reporting number, type, severity and cause of each problem encountered. Usability and Acceptance assessment is done with the score on respectively the System Usability Scale and the Technology Acceptance Model for the complete NESTORE Platform and for each single component in the different phases of use: Installation, Set-up, First use, Extended use.

Secondary

MeasureTime frame
For Feasibility, the secondary outcome is related to the preliminary assessment of efficacy, i.e. the possible improvement in the NESTORE well-being domains. For Usability, the secondary outcome is assumed to be the rate of users willingly to continue the intervention after the study (assessed 2 weeks after the conclusion of the study). For Acceptance, the secondary outcome measures are: - the drop-out rate (% of users abandoning the study because of lost interest) - the rate of users continuing the intervention after the study (assessed 2 weeks after the conclusion of the study).

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)